Datos Health: Feasibility, Safety, and Effectiveness of a Mobile Application Study Shows Datos’ TeleHealth Platform Improves Cardiac Rehab and Patient Adherence

June 30, 2020

Datos Health, a provider of hospital-grade automated remote care and telemedicine platforms, announced today the results of new research with Sheba Medical Center, showing that tele-cardiac rehabilitation (tele-CR) can improve adherence and exercise capacity among cardiac rehabilitation (CR) patients.

The clinical study, Feasibility, Safety, and Effectiveness of a Mobile Application in Cardiac Rehabilitation, published in the Israel Medical Association Journal (IMAJ), evaluated clinical and physiological outcomes, as well as patient adherence, to assess the viability of tele-CR as an alternative option to center-based rehabilitation. The six-month trial, performed with Sheba’s Cardiac Rehabilitation Center, is the first attempt to utilize digital health technology for remotely monitored cardiac rehabilitation.

“Despite the clear benefits of CR in reducing cardiac mortalities and improving the overall quality of life, it is often woefully underutilized for reasons including challenges in attending rehabilitation centers and interference with day-to-day life,” said Prof. Robert Klempfner, MD, Director of the Israeli Center for Cardiovascular Research and Scientific Director of the ARC Innovation Center at Sheba Medical Center. “The findings of this study reveal considerable advantages of tele-CR in the increase of adherence to exercise programs and improved patient outcomes.

The versatility of Datos’ remote care platform and its ability to increase patient engagement and adherence through personalization of the application is integral to making tele-CR a viable option for patients unable or unwilling to participate in center-based CR programs.”

Study results revealed significant improvement in exercise capacity and consistent adherence among patients, with over 63% completing the goal of 150 minutes of aerobic exercise per week. Overall patient satisfaction with the program was favorable, with a score of 4.05 out of 5. The success of the project resulted in the Israeli Ministry of Health defining a new reimbursement code for cardiac rehabilitation.

Patients received a smartphone application with a customized care plan, and monitoring devices that provided personalized feedback following each training session. Datos developed the application and accompanying care team dashboard to provide remote patient monitoring and continuity of care throughout the program. A dedicated care management portal provided care teams with information on patient adherence and progress.

“Remote care and telemedicine solutions are helping health systems to reduce costs and improve recovery through increased engagement between patients and their care teams outside of hospital settings,” said Uri Bettesh, CEO and Founder of Datos Heath. “As shown by the Ministry of Health’s actions, this can also effect positive regulatory change. However, success of such programs is dependent on developing strong partnerships between healthcare organizations and technology developers. Datos has enjoyed a long-standing relationship with Prof. Klempfner and his team at Sheba. This collaboration is further evidence of how together we can bring positive change to the provision of care for the benefit of large patient populations.”

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.